Fluid Dynamics and Thrombosis

  • Steven M. Slack
  • Winnie Cui
  • Vincent T. Turitto
Part of the NATO ASI Series book series (NSSA, volume 235)


Maintenance of blood fluidity and, conversely, arrest of bleeding at sites of vascular injury, depend on complex interactions between clotting factors, platelets, endothelial cells, the subendothelial matrix and proteins of the fibrinolytic pathway. Products generated by one system, e.g., the coagulation cascade, invariably either enhance or inhibit reactions in other pathways. Cleavage of high molecular weight kininogen, for example, amplifies the intrinsic pathway of coagulation and simultaneously releases bradykinin, a peptide with strong vasoconstrictive properties(1). Endothelial cells secrete prostacyclin (PGI2), a potent inhibitor of platelet activity, and both tissue plasminogen activator (t-PA) and t-PA inhibitor, components that play central roles in fibrinolysis(2). In addition, endothelial cells express thrombomodulin, a protein that plays a role in the thrombin-dependent activation of protein C and which ultimately results in the inactivation of Factors Va and VIIIa and release of plasminogen activators(3). Moreover, thrombin generated through the coagulation cascade converts fibrinogen to fibrin, which serves to stabilize developing hemostatic plugs but which also functions as a platelet activating agent.


Shear Rate Platelet Adhesion Wall Shear Rate High Molecular Weight Kininogen Platelet Membrane Glycoprotein 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Griffin JH, Cochrane CG: Recent advances in the understanding of contact activation reactions, Sem. Thromb. Hemostas., V: 254–272, 1979.Google Scholar
  2. 2.
    Gimbrone, MA: Vacular endothelium: Nature’s blood-compatible container, Ann. N.Y. Acad. Sci., 516: 5–11, 1987.PubMedCrossRefGoogle Scholar
  3. 3.
    Esmon CT: The protein C anticoagulant pathway, Arteriosclerosis and Thrombosis, 12: 135–145, 1992.PubMedCrossRefGoogle Scholar
  4. 4.
    Bird RB, Stewart WE, Lightfoot EN: Transport Phenomena, Wiley, New York, 1960.Google Scholar
  5. 5.
    Whitmore RL: Rheology of The Circulation, Pergamon Press, New York, 1968.Google Scholar
  6. 6.
    Middleman S. Transport Phenomena in the Cardiovascular System, John Wiley Sons, New York, 1972.Google Scholar
  7. 7.
    Goldsmith HL, Turitto VT: Rheological aspects of thrombosis and haemostasis: Basic principles and applications, Thromb. Haemostas., 55: 415–435, 1986.Google Scholar
  8. 8.
    Lowe GDO: Nature and clinical importance of blood rheology, In: Clinical Blood Rheology (Ed., Lowe GDO), CRC Press, Boca Raton, 1–10, 1988.Google Scholar
  9. 9.
    Eckstein EC, Tilles AW, Millero FJ: Conditions for the occurrence of large near-wall excesses of small particles during blood flow, Microvasc. Res., 36: 31–39, 1988.PubMedCrossRefGoogle Scholar
  10. 10.
    Eckstein EC, Belgacem F: Model of platelet transport in flowing blood with drift and diffusion terms, Biophys. J., 60: 53–69, 1991.PubMedCrossRefGoogle Scholar
  11. 11.
    Brown CH, et al.: Morphological, biochemical, and functional changes in human platelets subjected to shear stress, J. Lab. Clin. Med., 86: 462–471, 1975.PubMedGoogle Scholar
  12. 12.
    Moake JL, et al.: Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation, J. Clin. Invest., 78: 1456–1461, 1986.PubMedCrossRefGoogle Scholar
  13. 13.
    Moake JL, et al.: Shear-induced platelet aggregation can be mediated by vWF released by platelets, as well as exogenous large or unusually large vWF multimers, requires adenosine diphosphate, and is resistant to aspirin, Blood, 71: 1366–1374, 1988.PubMedGoogle Scholar
  14. 14.
    Ikeda Y, et al.: The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress, J. Clin. Invest., 87: 1234–1240, 1991.PubMedCrossRefGoogle Scholar
  15. 15.
    Tirrell MV: Stress-induced structure and activity changes in biologically active proteins, J. Bioeng., 2: 183–193, 1978.PubMedGoogle Scholar
  16. 16.
    Charm SE, Wong BL: Shear degradation of fibrinogen in the circulation, Science, 170: 466–468, 1970.PubMedCrossRefGoogle Scholar
  17. 17.
    Nollert MU, et al.: The effect of shear stress on the uptake and metabolism of arachidonic acid by human endothelial cells, Biochim. Biophys. Acta, 1005: 72–78, 1989.PubMedCrossRefGoogle Scholar
  18. 18.
    Diamond SL, Eskin SG, McIntire LV: Fluid flow stimulates tissue plasminogen activator secretion by cultured human endothelial cells, Science, 243: 1483–1485, 1989.PubMedCrossRefGoogle Scholar
  19. 19.
    Tesfamariam B, Cohen RA: Inhibition of adrenergic vasoconstriction by endothelial cell shear stress, Circ. Res., 63: 720–725, 1988.PubMedCrossRefGoogle Scholar
  20. 20.
    Cooke JP, et al.: Flow stimulates endothelial cells to release a nitrovasodilator that is potentiated by reduced thiol, Am. J. Physiol., 259: H804 - H812, 1990.PubMedGoogle Scholar
  21. 21.
    Buga GM, et al.: Shear stress-induced release of nitric oxide from endothelial cells grown on beads, Hypertension, 17: 187–193, 1991.PubMedCrossRefGoogle Scholar
  22. 22.
    Hsieh HJ, Li NQ, Frangos JA: Shear stress increases endothelial platelet-derived growth factor mRNA levels, Am. J. Physiol., 260: H642 - H646, 1991.PubMedGoogle Scholar
  23. 23.
    Jawien A, et al.: Platelet-derived growth factor promotes smooth muscle migration and intimai thickening in a rat model of balloon angioplasty, J. Clin. Invest., 89: 507–511, 1992.PubMedCrossRefGoogle Scholar
  24. 24.
    Lassila R, et al.: Dynamic monitoring of platelet deposition on severely damaged vessel wall in flowing blood, Arteriosclerosis, 10: 306–315, 1990.PubMedCrossRefGoogle Scholar
  25. 25.
    Weiss HJ, Turitto VT, Baumgartner HR: Role of shear rate and platelets in promoting fibrin formation on rabbit subendothelium., J. Clin. Invest., 78: 1072–1082, 1986.PubMedCrossRefGoogle Scholar
  26. 26.
    Gemmell CH, Nemerson Y, Turitto VT: The effects of shear rate on the enzymatic activity of the tissue factor-factor VIIa complex, Microvasc. Res., 40: 327–340, 1990.PubMedCrossRefGoogle Scholar
  27. 27.
    Goldsmith HL, Yu SS, Marlow J: Fluid mechanical stress and the platelet, Thromb. Diath. Haemorrh., 34: 32, 1975.PubMedGoogle Scholar
  28. 28.
    Baumgartner HR: The role of blood flow in platelet adhesion, fibrin deposition, and formation of mural thrombi, Microvasc. Res., 5: 167, 1973.PubMedCrossRefGoogle Scholar
  29. 29.
    Weiss HJ, Turitto VT, Baumgartner HR: Effect of shear rate on platelet interaction with subendothelium in citrated and native blood. I. Shear-rate dependent decrease of adhesion in von Willebrand’s disease and the Bernard-Soulier syndrome, J. Lab. Clin. Med., 92: 750, 1978.PubMedGoogle Scholar
  30. 30.
    Baumgartner HR, Turitto VT, Weiss HJ: Effects of shear rate on platelet interaction with subendothelium in citrated and native blood. II. Relationships among platelet adhesion, thrombus dimensions, and fibrin formation, J. Lab. Clin. Med., 95: 208, 1980.PubMedGoogle Scholar
  31. 31.
    Baumgartner HR, Sakariassen K: Factors controlling thrombus formation on arterial lesions, Ann. NY Acad. Sci., 454: 162, 1985.PubMedCrossRefGoogle Scholar
  32. 32.
    Turitto VT, Baumgartner HR: Platelet interaction with subendothelium in flowing rabbit blood: Effect of blood shear rate, Microvasc. Res., 17: 38–54, 1979.PubMedCrossRefGoogle Scholar
  33. 33.
    Furkin BG, Howard MA: On von Willebrand’s disease, Br. J. Haemotol., 32: 151, 1976.CrossRefGoogle Scholar
  34. 34.
    Baumgartner HR, Tschopp TB, Weiss HJ: Platelet interaction with collagen fibrils in flowing blood. II. Impaired adhesion-aggregation in bleeding disorders-a comparison with subendothelium, Thromb. Haemostas., 37: 17, 1977.Google Scholar
  35. 35.
    Tschopp TB, Weiss HJ, Baumgartner HR: Decreased adhesion of platelets to subendothelium in von Willebrand’s disease, J. Lab. Clin. Med., 83: 296, 1974.PubMedGoogle Scholar
  36. 36.
    Baumgartner HR, Tschopp TB, Meyer D: Shear rate-dependent inhibition of platelet adhesion and aggregation on collagenous surfaces by antibodies to human factor VIII/von Willebrand factor, Br. J. Haemotol., 44: 127, 1980.CrossRefGoogle Scholar
  37. 37.
    Badimon L, et al.: Role of von Willebrand factor in mediating platelet-vessel wall interaction at low shear rates: The importance of perfusion conditions, Blood, 73: 961, 1989.PubMedGoogle Scholar
  38. 38.
    Weiss HJ, et al.: Correction by factor VIII of the impaired platelet adhesion to subendothelium in von Willebrand’s disease, Blood, 51: 267, 1978.PubMedGoogle Scholar
  39. 39.
    Sakariassen KS, Bolhuis PA, Sixma JJ: Human blood platelet adhesion to artery subendothelium is mediated by factor VIII-vWF bound to the subendothelium, Nature, 279: 636, 1979.PubMedCrossRefGoogle Scholar
  40. 40.
    Bolhuis PA, et al.: Binding of factor VIII-von Willebrand factor to human arterial subendothelium precedes increased platelet adhesion and enhances platelet spreading, J. Lab. Clin. Med., 97: 568, 1981.PubMedGoogle Scholar
  41. 41.
    Turitto VT, Weiss HJ, Baumgartner HR: Decreased platelet adhesion on vessel segments in von Willebrand’s disease: A defect in initial platelet attachment, J. Lab. Clin. Med., 102: 551, 1983.PubMedGoogle Scholar
  42. 42.
    Rand JH, et al.: 150 kDa vWF binding protein extracted from human vascular subendothelium is a type VI-like collagen, Clin. Res., 36:417a.Google Scholar
  43. 43.
    Neuwenhuis HK, et al.: Deficiency of platelet membrane glycoprotein lb associated with a decreased platelet adhesion to subendothelium: A defect in platelet spreading, Submitted.Google Scholar
  44. 44.
    Zimmerman TS, Ruggeri ZM: Von Willebrand’s disease, Prog. Hemostas. Thromb., 6: 203, 1982.Google Scholar
  45. 45.
    Mourik JAV, et al.: Factor VIII, a series of homologous oligomers and a complex of two proteins, Thromb. Res., 4: 155, 1974.PubMedCrossRefGoogle Scholar
  46. 46.
    Hoyer LW, Shinoff JR: Factor VIII-related protein circulates in normal human plasma as high molecular weight multimers, Blood, 55: 1056, 1980.PubMedGoogle Scholar
  47. 47.
    Sixma JJ, et al.: Adhesion of platelets to human artery subendothelium: Effects of factor VIII-von Willebrand factor of various multimeric composition, Blood, 63: 128, 1984.PubMedGoogle Scholar
  48. 48.
    Jenkins CSP, et al.: Platelet membrane glycoproteins implicated in ristocetininduced aggregation: Studies of the proteins on platelets from patients with Bernard-Soulier syndrome and von Willebrand’s disease, J. Clin. Invest., 57: 112, 1976.PubMedCrossRefGoogle Scholar
  49. 49.
    Roth GJ: Developing relationships: Arterial platelet adhesion, glycoprotein lb, and leucine-rich glycoproteins, Blood, 77: 5–19, 1991.PubMedGoogle Scholar
  50. 50.
    Fujimura Y, Ruggeri ZM, Zimmerman TS: Structure and function of human von Willebrand factor, In: Coagulation and Bleeding Disorders: The Role of Factor VIII and von Willebrand Factor (Ed, Zimmerman TS, Ruggeri Z), Marcel Dekker, New York, 77, 1989.Google Scholar
  51. 51.
    Girma J, et al.: Structure-function relationship of human von Willebrand factor, Blood, 70: 605, 1987.PubMedGoogle Scholar
  52. 52.
    Turitto VT, Weiss HJ, Baumgartner HR: Platelet interaction with rabbit subendothelium in von Willebrand’s disease: Altered thrombus formation distinct from defective platelet adhesion, J. Clin. Invest., 74: 1730–1741, 1984.PubMedCrossRefGoogle Scholar
  53. 53.
    Peterson DM, et al.: Shear-induced platelet aggregation requires von Willebrand factor and platelet membrane glycoproteins lb and Ilb-IIIa, Blood, 69: 625–628, 1987.PubMedGoogle Scholar
  54. 54.
    Ikeda Y, et al.: Inportance of fibrinogen and platelet membrane glycoprotein IIb/IIIa in shear-induced platelet aggregation, Thromb. Res., 51: 157–163, 1988.PubMedCrossRefGoogle Scholar
  55. 55.
    Packham MA, Mustard JF: The role of platelets in the development and complications of atherosclerosis, Semin Hematol., 23: 8–26, 1986.PubMedGoogle Scholar
  56. 56.
    Woolf N, Davies MJ: Interrelationship between atherosclerosis and thrombosis, In: Thrombosis in Cardiovascular Disorders (Ed., Fuster V, Verstraete M), W.B. Saunders, Philadelphia, 41–78, 1992.Google Scholar
  57. 57.
    Ross R, et al.: A platelet dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro, Proc. Natl. Acad. Sci. USA, 71: 1207–1210, 1974.PubMedCrossRefGoogle Scholar
  58. 58.
    Badimon L, Badimon JJ: Mechanisms of arterial thrombosis in nonparallel streamlines: Platelet thrombi grow on the apex of stenotic severely injured vessel wall, J. Clin. Invest., 84: 1134–1144, 1989.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1992

Authors and Affiliations

  • Steven M. Slack
    • 1
  • Winnie Cui
    • 1
  • Vincent T. Turitto
    • 1
  1. 1.Department of Biomedical EngineeringMemphis State UniversityMemphisUSA

Personalised recommendations